NCT04721340 is a clinical trial of Test Group in Multiple Sclerosis, sponsored by Istanbul Aydın University.

Who is sponsoring NCT04721340?

NCT04721340 is sponsored by Istanbul Aydın University.

What drugs are being tested in NCT04721340?

Interventions in NCT04721340: Test Group, Control Grup.

What condition does NCT04721340 study?

NCT04721340 studies Multiple Sclerosis.

Is NCT04721340 still recruiting?

NCT04721340 is currently completed. Last updated 15 June 2021.

Last reviewed 2021-06-15 · How we verify

NCT04721340

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Minnesota Manual Dexterity Test As A Measure Of Hand Function in Multiple Sclerosis

Completed Last updated 15 June 2021

What this trial tests

trial testing Test Group in Multiple Sclerosis in 80 participants. Completed in 16 May 2021.

Timeline

2 February 2021

Primary endpoint
2 May 2021

16 May 2021

Quick facts

Lead sponsor	Istanbul Aydın University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	2 February 2021
Primary completion	2 May 2021
Estimated completion	16 May 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Test Group
Control Grup

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Istanbul Aydın University

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to report the results of manual dexterity using the Minnesota Manual Dexterity Test in people with Multiple Sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Test Group

Trials testing the same drug.

NCT06063239 — Probiotics in Special Needs Patients at High Risk for Tooth Decay: a Randomized Controlled Trial. · NA · unknown
NCT05820139 — Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery · NA · completed
NCT04723069 — Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases · Phase 2 · completed
NCT02300090 — A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD) · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Istanbul Aydın University trials

Trials by the same sponsor.

NCT07472998 — Heart Rate Variability in Benign Paroxysmal Positional Vertigo · recruiting
NCT07502079 — The Impact of Technology-supported Interactive Teaching in Ethics Education · NA · not yet recruiting
NCT07502547 — The Effect of a Mindfulness-Based Stress Reduction Program on Feelings of Being a Geriatric Burden in Older Women · NA · active not recruiting
NCT07291310 — Virtual Reality and Dual-Task Training for Cortical Plasticity in Children With Brachial Plexus Injury · NA · not yet recruiting
NCT07512895 — The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treat · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04721340 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Aydın University
Last refreshed: 15 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04721340.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing